Orin Hirschman 13D and 13G filings for AVEO Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-20 4:05 pm Sale | 2022-10-16 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Orin Hirschman | 975,993 2.800% | -1,735,377 (-64.00%) | Filing |
| 2022-02-11 3:32 pm Purchase | 2021-12-31 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Orin Hirschman | 2,711,370 7.900% | 669,559 (+32.79%) | Filing |
| 2021-09-14 6:11 pm Purchase | 2021-09-03 | 13G | AVEO Pharmaceuticals, Inc. AVEO | Orin Hirschman | 2,041,811 5.940% | 2,041,811 (New Position) | Filing |